Skip to main content
Unknown status

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 70

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 6837|2006-004592-35

Study First Received: January 19, 2011

Last Updated: November 19, 2014

Estimated Primary Completion Date: January 2015

 

Primary Outcome Measures:

progression-free survival|response rate|overall survival|time to progression|safety (adverse events)

Sponsors and Collaborators:

Barts & The London NHS Trust|Cancer Research UK|UK: Barts Center for Experimental Cancer Medicine (CECM) for Trial Coordination

Website Link: https://ClinicalTrials.gov/show/NCT01279967

Leave a Reply